Literature DB >> 2340255

Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour.

S K Hendricks1, J R Smith, D E Moore, Z A Brown.   

Abstract

The use of prostaglandin synthetase inhibitors (indomethacin and ibuprofen) for greater than 72 h in women with preterm labour (n = 67) was significantly (P less than 0.001) associated with ultrasound-recorded oligohydramnios compared with the use of ritodrine or magnesium sulphate (control group, n = 67). Oligohydramnios developed in 26 of 37 women (70%) treated with indomethacin and 8 of 30 women treated with ibuprofen (27%) (P less than 0.01). Oligohydramnios developed in only two control subjects and one of these pregnancies was associated with intrauterine growth retardation. All 34 cases of oligohydramnios in the treatment group resolved after stopping medication, whereas the two in the control group did not resolve. No instances of renal failure, premature closure of the ductus arteriosus, pulmonary hypertension, or bleeding disorders were noted in any of the treated or control infants.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340255     DOI: 10.1111/j.1471-0528.1990.tb01807.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  3 in total

1.  Regulation of sPLA2-IID in Human Decidua: Insights Into the Complexity of the Prostaglandin Pathway in Labor.

Authors:  Andrea A Mosher; Kelly J Rainey; Brigitta Riley; Hayley S Levinson; Angela E Vinturache; Stephen L Wood; Donna M Slater
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

Review 2.  Migraine during pregnancy: is it more than a headache?

Authors:  Stephen A Contag; Heather L Mertz; Cheryl D Bushnell
Journal:  Nat Rev Neurol       Date:  2009-07-14       Impact factor: 42.937

3.  Uterus-targeted liposomes for preterm labor management: studies in pregnant mice.

Authors:  Jerrie S Refuerzo; Fransisca Leonard; Nataliya Bulayeva; David Gorenstein; Giuseppe Chiossi; Alejandra Ontiveros; Monica Longo; Biana Godin
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.